CVC Catalyst agrees to buy majority stake in prosthetics maker WillowWood

  • CVC Catalyst III agreed to buy a majority stake in prosthetics products maker WillowWood from Blue Sea Capital, the Arbogast family, management.
  • Blue Sea, the Arbogast family, management will reinvest alongside CVC; financial terms were not disclosed.
  • WillowWood will remain led by co-CEOs Mahesh Mansukhani and Daniel Rubin; Ryan Arbogast will continue supporting the business.
  • CVC plans to increase R&D investment, pursue acquisitions, expand internationally, including building a direct commercial footprint in Europe.
  • Closing is expected in Q3 2026, subject to regulatory approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVC Advisers Ltd. published the original content used to generate this news brief on June 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.